| 000 | 01181 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517194603.0 | ||
| 264 | 0 | _c20190117 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2018.01.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJerlhag, Elisabet | |
| 245 | 0 | 0 |
_aGLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence. _h[electronic resource] |
| 260 |
_bNeuropharmacology _c07 2018 |
||
| 300 |
_a343-349 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAlcohol Drinking _xdrug therapy |
| 650 | 0 | 4 |
_aAlcoholism _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCentral Nervous System Depressants _xpharmacology |
| 650 | 0 | 4 |
_aEthanol _xpharmacology |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xmetabolism |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide-1 Receptor _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor Agonists |
| 773 | 0 |
_tNeuropharmacology _gvol. 136 _gno. Pt B _gp. 343-349 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2018.01.013 _zAvailable from publisher's website |
| 999 |
_c27983152 _d27983152 |
||